Showing results (11-20 of 74) with videos related to
Sort By:
Pageof 8
Expert Review of Neurotherapeutics|December 13, 2016
The use of modified-release methylphenidate in the treatment of attention-deficit/hyperactivity disorderAnn Childress, Dmitry Belchenko, Brian LempaExpert Opinion on Pharmacotherapy|January 24, 2020
Evaluation of the current data on guanfacine extended release for the treatment of ADHD in children and adolescentsAnn Childress, Asmara Hoo-Cardiel, Peter LangExpert Opinion on Drug Delivery|November 9, 2018
QuilliChew extended-release chewable tablets for the treatment of ADHD in patients ages 6 years old and aboveAnn Childress, Bernice Ponce De Leon, Mark OwensNPJ Digital Medicine|March 27, 2021
Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHDScott H Kollins, Ann Childress, Andrew C Heusser, et al.Postgraduate Medicine|September 24, 2010
Open-label administration of lisdexamfetamine dimesylate improves executive function impairments and symptoms of attention-deficit/hyperactivity disorder in adultsThomas E Brown, Matthew Brams, Joseph Gao, et al.Clinical Pharmacology in Drug Development|May 26, 2017
A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy AdultsAnn Childress, Jeffrey G Stark, Russ McMahen, et al.Journal of Medical Economics|April 11, 2024
Costs associated with adverse events during treatment episodes for adult attention-deficit/hyperactivity disorderJeff Schein, Martin Cloutier, Rebecca Bungay, et al.Journal of Attention Disorders|June 30, 2021
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHDAnn Childress, Andrew J Cutler, Andrea H Marraffino, et al.Postgraduate Medicine|November 1, 2017
Effects of SHP465 mixed amphetamine salts in adults with ADHD in a simulated adult workplace environmentTimothy Wigal, Ann Childress, Glen Frick, et al.Psychopharmacology Bulletin|March 26, 2008
Treatment of children with attention-deficit/hyperactivity disorder: results of a randomized, multicenter, double-blind, crossover study of extended-release dexmethylphenidate and D,L-methylphenidate and placebo in a laboratory classroom settingRaul Silva, Rafael Muniz, Kevin McCague, et al.Pageof 8